R21 Roche: 3-Way Tau Tracers in AD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
R21 Roche: 3-Way Tau Tracers in AD	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Active, not recruiting	Phase 1	2026-05-08		NCT05464368

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hoffmann-La Roche	280
Washington University School of Medicine	475

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Washington University School of Medicine	St Louis	United States	895

Clinical trials